No.88：医師によるCOVID-19治療薬処方の違い／肥満に対するオルリスタット【Podcast：にゃんごう＆いがさんのEBMerな夜】

にゃんごう＆いがさんのEBMerな夜
第88回放送　2024/3/18

【にゃんごう：医師によるCOVID-19治療薬処方の違い】
Miyawaki A, Kitajima K, Iwata A, Sato D, Tsugawa Y.
Physician characteristics associated with antiviral prescriptions for older adults with COVID-19 in Japan: an observational study.
BMJ Open. 2024 Mar 15;14(3):e083342. doi: 10.1136/bmjopen-2023-083342.
PMID: 38490659.
https://bmjopen.bmj.com/content/14/3/e083342

【いがさん：肥満に対するオルリスタット】
Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.
Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
JAMA. 2005 Jun 15;293(23):2873-83. doi: 10.1001/jama.293.23.2873. Erratum in: JAMA. 2005 Sep 28;294(12):1491.
PMID: 15956632.
https://jamanetwork.com/journals/jama/fullarticle/201079

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Erratum in: JAMA. 2016 Sep 6;316(9):995.
PMID: 27299618; PMCID: PMC5617638.
https://jamanetwork.com/journals/jama/fullarticle/2528211

リスナーアンケートにご協力下さい！！
https://goo.gl/forms/5AsPilK7QnB9VrmX2